Case number 1:23-cv-00774
Gilead Sciences, Inc. v. Apotex Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 5, 2023 | N/A | CORRECTING ENTRY: The signed Stipulation and Order of Infringement and Consolidation has been added to D.I. 13 . (dlw) (Entered: 10/05/2023) (0) |
| Sep 18, 2023 | N/A | CORRECTING ENTRY: D.I. 14 and 15 have been deleted from the docket. Pursuant to the Stipulation of Infringement and Consolidation Order, all filings are to be made in Lead Case C.A. No. 21-1621. (dlw) (Entered: 09/18/2023) (0) |
| Aug 14, 2023 | 13 | SO ORDERED re (151 in 1:21-cv-01621-MN, 12 in 1:23-cv-00774-MN) Stipulation and Order of Infringement and Consolidation. Signed by Judge Maryellen Noreika on 8/14/2023. (dlw) (dlw). (Entered: 08/14/2023) (6) |
| Aug 14, 2023 | N/A | Case associated with lead case: Create association to 1:21-cv-01621-MN. (dlw) (Entered: 08/14/2023) (0) |
| Aug 11, 2023 | 12 | STIPULATION of Infringement and Consolidation and [Proposed] Order by Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P., Janssen Sciences Ireland Unlimited Company. (Tigan, Jeremy) (Entered: 08/11/2023) (6) |
| Jul 26, 2023 | 7 | WAIVER OF SERVICE returned executed by Gilead Sciences, Inc.: For Apotex Corp. waiver sent on 7/18/2023, answer due 9/18/2023. (Tigan, Jeremy) (Entered: 07/26/2023) (1) |
| Jul 26, 2023 | 8 | WAIVER OF SERVICE returned executed by Gilead Sciences, Inc.: For Apotex Inc. waiver sent on 7/18/2023, answer due 9/18/2023. (Tigan, Jeremy) (Entered: 07/26/2023) (1) |
| Jul 26, 2023 | 9 | WAIVER OF SERVICE returned executed by Gilead Sciences, Inc.: For MSN Laboratories Private Ltd. waiver sent on 7/24/2023, answer due 9/22/2023. (Tigan, Jeremy) (Entered: 07/26/2023) (1) |
| Jul 26, 2023 | 10 | WAIVER OF SERVICE returned executed by Gilead Sciences, Inc.: For MSN Life Sciences Private Ltd. waiver sent on 7/24/2023, answer due 9/22/2023. (Tigan, Jeremy) (Entered: 07/26/2023) (1) |
| Jul 26, 2023 | 11 | WAIVER OF SERVICE returned executed by Gilead Sciences, Inc.: For MSN Pharmaceuticals Inc. waiver sent on 7/24/2023, answer due 9/22/2023. (Tigan, Jeremy) (Entered: 07/26/2023) (1) |
| Jul 19, 2023 | N/A | Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. Associated Cases: 1:23-cv-00774-MN, 1:23-cv-00775-MN (rjb) (Entered: 07/19/2023) (0) |
| Jul 14, 2023 | 1 | Complaint* (1) |
| Jul 14, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 07/17/2023) (3) |
| Jul 14, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: June 2, 2023. Date of Expiration of Patent: October 6, 2032 & April 6, 2033 with PED. Thirty Month Stay Deadline: 12/2/2025. (Entered: 07/17/2023) (2) |
| Jul 14, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,039,718 B2. (jfm) (Entered: 07/17/2023) (1) |
| Jul 14, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Gilead Sciences, Inc. (jfm) (Entered: 07/17/2023) (1) |
| Jul 14, 2023 | 6 | Summonses Issued as to Apotex Corp., Apotex Inc., MSN Laboratories Private Ltd., MSN Life Sciences Private Ltd., and MSN Pharmaceuticals Inc. on 7/14/2023. (Attachments: # 1 Summons Issued Apotex Inc., # 2 Summons Issued MSN Laboratories Private Limited, # 3 Summons Issued MSN Life Sciences Private Ltd., # 4 Summons Issued MSN Pharmaceuticals Inc.)(jfm) (Entered: 07/17/2023) (0) |
